Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation

Area of Science:

• Pulmonary Medicine
• Immunology
• Proteomics

Background:

• Cytokines are key signaling proteins implicated in chronic obstructive pulmonary disease (COPD) pathogenesis.
• Understanding cytokine profiles in COPD, especially during exacerbations, is crucial for disease management.

Purpose of the Study:

• To investigate differential cytokine expression at mRNA and protein levels in sputum from healthy individuals, stable COPD patients, and those with acute exacerbations of COPD (AECOPD).

Main Methods:

• Sputum samples were collected from healthy controls, stable COPD patients, and AECOPD patients (at admission and discharge).
• Cytokine protein levels were analyzed using antibody microarrays (120 cytokines).
• mRNA expression of 14 selected cytokines was assessed via real-time PCR (qPCR).

Main Results:

• Interleukin-6 and Growth-Regulated Oncogene-alpha were differentially expressed in stable COPD vs. healthy controls.
• AECOPD onset showed altered sputum cytokine profiles compared to stable COPD.
• Recovery from AECOPD led to cytokine profile changes, but levels often remained elevated post-hospitalization.

Conclusions:

• The sputum cytokine signature of AECOPD is distinct from stable COPD.
• Protein and mRNA expression changes in AECOPD are asynchronous.
• Acute exacerbations of COPD have a prolonged effect on patient cytokine status, extending beyond hospitalization.